FeRiva 21/7
by Avion Pharmaceuticals · Tablet or Pill
Supplement facts from the label of FeRiva 21/7 by Avion Pharmaceuticals: Vitamin C 175 mg, Zinc 10 mg, Vitamin B12 12 mcg, Iron 75 mg….

Supplement Facts
| Ingredient | Per serving | % DV | Upper limit (adults) |
|---|---|---|---|
| Vitamin C (Ascorbic Acid) | 175 mg | 292% | 2,000 mg · 9% at label max |
| Zinc (Zinc Bisglycinate) | 10 mg | 67% | 40 mg · 25% at label max |
| Vitamin B12 (Cyanocobalamin) | 12 mcg | 200% | — |
| Iron (Ferrous Asparto Glycinate) | 75 mg | 417% | 45 mg · 167% at label max ⚠ |
| Folate | 1,200 mcg DFE | 430% | — |
| └ (6S)-N5-Methyltetrahydrofolic Acid Calcium Salt | 800 mcg | — | — |
| └ Folic Acid | 400 mcg | — | 1,000 mcg · 40% at label max |
| Succinic Acid | 150 mg | — | — |
⚠ Above the upper limit: at the most servings a day printed on the label, at least one ingredient goes above the adult UL. Some ULs apply only to supplemental forms (shown on each ingredient page).
Upper limits: NIH ODS Fact Sheets for Health Professionals. Compared only where the unit converts and the limit applies to the form on the label.
On the label
For: Adult (18 - 50 Years) · Pregnant Women · Lactating
Claim types: Nutrient · All Other · Structure/Function
All Other Content: 75854-318-28 RX only
Formulation re: Other: Unique, innovative iron supplementation system Enhanced GI tolerability Improved absorption Easy-to-swallow tablets
Suggested/Recommended/Usage/Directions: Once daily 28-day iron supplement regimen
Formula re: Contains: Description: FeRiva 21/7 tablets for oral administration is a 28-day iron supplement regimen that consists of 21 red, oval-shaped iron tablets and 7 purple, oval-shaped placebo tablets. Each red, oval-shaped iron tablet is debossed with “21” and “7” separated by a line in the middle on the top-side of the tablet and blank on the other side. Each purple, oval shaped placebo tablet is blank on both
Formulation re: Other: Indications: FeRiva 21/7 is a multivitamin/multimineral dietary supplement indicated for use in improving the nutritional status of patients with iron deficiency. Contraindictions: FeRiva 21/7 is contraindicated in patients with a known hypersensitivity to any of the ingredients. Hemochromatosis and hemosiderosis are contraindicated to iron therapy.
Precautions re: Children: Warning: Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. Keep this product out of reach of children. In case of accidental overdose, call a doctor or poison control center immediately.
This page repeats what the label says and the official upper limits for healthy adults. It is not medical advice: ask a doctor, pharmacist or registered dietitian about your own intake, especially if you are pregnant, take medicines or have a health condition.
Label data: NIH Office of Dietary Supplements, Dietary Supplement Label Database (dsld.od.nih.gov), public domain. Upper limits: NIH ODS Fact Sheets for Health Professionals (values from the Institute of Medicine, Food and Nutrition Board).